Chien-Ting Chen

Title: Innovations in Anticancer Agents by Chien-Ting Chen

Introduction

Chien-Ting Chen is a prominent inventor based in Taichung, Taiwan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer agents. With a total of 4 patents to his name, Chen's work focuses on innovative compounds that show promise in cancer treatment.

Latest Patents

Chen's latest patents include the development of 2-phenyl-4-quinolones as anticancer agents. In this innovative process, 2-aryl-4-quinolones are converted into phosphates by reacting with tetrabenzyl pyrophosphate to form dibenzyl phosphates. These phosphates are then subjected to hydrogenation to replace dibenzyl groups with hydrogen, followed by a reaction with Amberlite IR-120 (Naform) to form disodium salts. Preliminary screening results have revealed that these phosphates exhibit significant anti-cancer activity. Additionally, a novel intermediate, 2-selenophene 4-quinolone, along with N,N-dialkylaminoalkyl derivatives of 2-phenyl-4-quinolones, have also been synthesized, demonstrating significant anticancer activities.

Career Highlights

Chien-Ting Chen is affiliated with China Medical University, where he continues to advance his research in the field of anticancer agents. His work has garnered attention for its potential impact on cancer treatment and therapeutic development.

Collaborations

Chen has collaborated with notable colleagues, including Sheng-Chu Kuo and Che-Ming Teng, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Chien-Ting Chen's innovative work in the development of anticancer agents highlights his significant contributions to medicinal chemistry. His research not only advances scientific knowledge but also holds the potential for impactful applications in cancer treatment.